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OBJECTIVE: To investigate the feasibility and the cardiorespiratory effects of using positive expiratory airway pressure, a phys-
iotherapeutic tool, in comparison with a T-tube, to wean patients from mechanical ventilation.
METHODS/DESIGN: A prospective, randomized, cross-over study. 
SETTING: Two intensive care units. 
PATIENTS AND INTERVENTIONS: We evaluated forty patients who met weaning criteria and had been mechanically-ventilated 
for more than 48 hours, mean age 59 years, including 23 males. All patients were submitted to the T-tube and Expiratory Positive 
Airway Pressure devices, at 7 cm H2O, during a 30-minute period. Cardiorespiratory variables including work of breathing, respira-
tory rate (rr), peripheral oxygen saturation (SpO2), heart rate (hr), systolic, diastolic and mean arterial pressures (SAP, DAP, MAP) 
were measured in the first and thirtieth minutes. The condition was analyzed as an entire sample set (n=40) and was also divided 
into subconditions: chronic obstructive pulmonary disease (n=14) and non-chronic obstructive pulmonary disease (non- chronic 
obstructive pulmonary disease) (n=26) categories. Comparisons were made using a t-test and Analysis of Variance. The level of 
significance was p < 0.05. 
RESULTS: Our data showed an increase in work of breathing in the first and thirtieth minutes in the EPAP condition (0.86+ 0.43 and 
1.02+1.3) as compared with the T-tube condition (0.25+0.26 and 0.26+0.35) (p<0.05), verified by the flow-sensor monitor (values 
in J/L). No statistical differences were observed when comparing the Expiratory Positive Airway Pressure and T-tube conditions 
with regard to cardiorespiratory measurements. The same result was observed for both chronic obstructive pulmonary disease and 
non- chronic obstructive pulmonary disease subconditions.
CONCLUSIONS: Our study demonstrated that, in weaning patients from mechanical ventilation, the use of a fixed level of 
Expiratory Positive Airway Pressure caused an increase in work of breathing that was not accompanied by any other significant 
cardiorespiratory changes. Therefore, we have to be cautious when using Expiratory Positive Airway Pressure as a physiotherapeutic 
tool during weaning from mechanical ventilation.
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INTRODUCTION
The discontinuation or withdrawal process from 
mechanical ventilation is an important clinical challenge. 
Up to 40% of the time spent during mechanical ventilation 
is devoted to weaning, which is described as the process of 
gradual and progressive removal of ventilatory support.1,2 
Formal discontinuation assessment for patients who receive 
mechanical ventilation for respiratory failure should be 
performed during spontaneous breathing rather than while 
the patient is still receiving substantial ventilatory support. 
An initial brief period of spontaneous breathing can be 
used to assess the advisability of continuing onto a formal 
Spontaneous Breathing Trial (SBT).3-5
The most important mechanisms that lead to unsuccessful 
weaning include alterations in respiratory drive, impaired 
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oxygenation, and excessive load being imposed on 
respiratory muscles.6 Certain studies suggest that the 
application of external Positive Expiratory Pressure (PEP) 
during mechanical ventilation minimizes hyperinflation 
effects and reduces the work of breathing, which may be 
helpful during the weaning process.7
Positive Expiratory Airway Pressure (EPAP) is a 
technique that has been used as an effective and safe 
alternative to chest physiotherapy. During EPAP therapy, 
the patient exhales against a threshold resistor, generating 
preset positive expiratory pressures. The purpose of this 
therapy is to increase the transpulmonary pressure gradient 
and improve pulmonary expansion, which consequently 
improves oxygenation.8,9 EPAP can mobilize secretions, help 
in the management of post-operative atelectasis, and enhance 
the benefits of aerosol bronchodilator delivery. It is also 
known that EPAP and Continuous Positive Airway Pressure 
(CPAP) can reduce inspiratory load, possibly secondary to a 
reduction in hyperinflation.10 Hyperinflation with a decrease 
in inspiratory capacity is a common presentation in some 
patients, such as those with asthma and COPD and there 
is some evidence advocating the use of EPAP in Intensive 
Care Units (ICU) to reduce air trapping in those patients.11 
To our knowledge, no research to date has compared the use 
of EPAP and T-tube devices in weaning patients.
This study aims to investigate the feasibility of EPAP as 
a physiotherapy tool in weaning patients from mechanical 
ventilation, evaluating its short term hemodynamic and 
respiratory effects. 
MATERIALS AND METHODS
Study Population
This study took place between January 2005 and July 
2007, in two Intensive Care Units (ICU). The sample 
condition was composed of 40 critically ill patients who 
had been on mechanical ventilation for more than 48 hours, 
with different causes of respiratory failure. Their clinical 
characteristics are displayed in Table 1.
Patients considered fit for weaning were selected by ICU 
physicians on the basis of the routinely applied ICU criteria, 
which included improvement or resolution of the cause of 
respiratory failure; adequate gas exchange, indicated by PaO2 
/ FiO2 > 200 or PaO2 > 60 mmHg; oxygen saturation > 90%, 
FiO2 < 0.40, with PEEP < 5 cmH2O; Glasgow Coma Score > 
13; absence of hyperthermia; acceptable hemoglobin levels; 
respiratory rate (RR) < 35 breaths/min; tidal volume (VT) 
on non-assisted breathing > 5 mL/kg; maximum inspiratory 
pressure (PI max) < -20 cmH2O; and hemodynamic stability 
without the use of vasoactive drugs (dopamine, dobutamine 
or norepinephrine) or sedatives. Exclusion criteria included 
patients with hypotension (systolic blood pressure < 100 
mmHg) due to hypovolemia or direct cardiovascular 
involvement; patients using vasoactive drugs (dopamine, 
dobutamine or norepinephrine); patients with severe 
intracranial disease, with barotrauma and/or chest tubes; and 
those using sedatives. This study was approved by the ethics 
committees of both hospitals. All participating patients or 
their relatives signed an informed consent form.
Design
This study was a cross-over randomized clinical trial. 
Each patient was observed during the use of both T-tube 
(control) and EPAP methods. The sequence in which the 
methods were implemented was determined by random 
selecting sealed envelopes. 
All patients entering the study were ventilated either 
on Servo 900C or on Servo 300C (Siemens-Elema, Solna, 
Sweden) systems under low levels of Pressure Support 
Table 1 - Patient Clinical Features 
  
Characteristics  
Mean Age (years) ± SD 59.4 + 18.1
Gender  N (%)  
   Male 23 (57.5)
   Female 17 (42.5)
Mean ICU admission APACHE II ± SD 13.3 + 10.4
Mechanical Ventilation durations (days)   N (%)  
   < 5  13 (32.5)
   5 - 10  13 (32.5)
   > 10  14 (35.0)
COPD  
   COPD  14 (35.0)
   Non-COPD   26 (65.0)
Etiology of Respiratory Failure N (%)  
   Acute Respiratory Distress Syndrome (ARDS) 10 (25.0)
   Acute Pulmonary Edema (APE)   8 (20.0)
   COPD   8 (20.0)
   Coma   4 (10.0)
   Pneumonia   3   (7.5)
   Post-op   3   (7.5)
   Cardiopulmonary Resuscitation (CPR)   3   (7.5)
   Guillian-Barré Syndrome   1   (2.5)
SD = Standard Deviation; ICU = Intensive Care Unit; APACHE = Acute 
Physiology and Chronic Health Evaluation II; COPD = chronic obstructive 
pulmonary disease; ARDS = Acute Respiratory Distress Syndrome; APE = 
acute pulmonary edema; Post-op = Postoperative; CPR = Cardiopulmonary 
Resuscitation.
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(PS) < 12 cmH2O, before commencing the protocol. The 
following information on each patient’s clinical status was 
registered in standard formats: age, sex, APACHE Scale II 
(Acute Physiology and Chronic Health Evaluation II), and 
time of mechanical ventilation.
Mechanical ventilation parameters registered prior to 
protocol commencement included ventilation mode, PS level, 
Fractional Concentration of Oxygen (FiO2), Tidal Volume 
(VT), Respiratory Rate (RR), and peak inspiratory pressure 
(PIP). Arterial blood gas analysis, performed prior to our 
protocol, was also recorded. Patients were then submitted to 
either T-tube or EPAP treatment in a random order.
During T-tube treatment, the patient was disconnected 
from mechanical ventilation, and an oxygen flow of 5 L/min 
was added to the endotracheal tube (ETT) or tracheostomy. 
Inspiratory and expiratory breathing efforts were made 
spontaneously by the patient. Oxygen flow added to the 
T-tube was kept at 5 L/min.
During EPAP, patients breathed spontaneously through 
the EPAP system adapted for either the ETT or tracheostomy. 
The EPAP system consisted of a T-tube with a unidirectional 
inspiratory valve and a spring-loaded expiratory valve. 
Pressure was maintained at 7 cmH2O, the same value used 
during PS by other authors. Oxygen flow was 5 L/min.12,13
Data Collection
To monitor ventilatory mechanics, a Ventrak Model 1500 
(Novametrix Medical Systems, Wallingford, CT, USA) was 
used. This device continuously processes readings from a flow 
sensor (Disposable Flow Sensor, cat. No 6038, Novametrix 
Medical Systems, Wallingford, CT, USA) that is positioned 
between the end of the ETT or tracheostomy and the T-tube, 
both with or without EPAP. The flow sensor converts gas 
flow into a linear signal, identifying the differences in circuit 
flow and pressure. The Ventrak 1500 is attached to a portable 
IBM-compatible computer (Fujitsu, mod. 756 DX, Japan) via 
a serial port. We used software supplied by Novametrix for 
data storage and subsequent analysis. 
Pressure on the ETT and tracheostomy was checked at 
the onset of Ventrak 1500 measurements in order to ensure 
there was no leakage of exhaled air, which may impair the 
recording of variables. The Ventrak 1500 is supplied with its 
own flow and pressure calibration software, which we used 
at the beginning of each monitoring period. Calibration was 
performed with a 100 mL Calibration Syringe. (Model No 
5510, Hans Rudolph, Kansas City, Mo., USA). Variables 
recorded by the Ventrak system included work of breathing 
(WOBtotal = J/L) and tidal volume.
The HP Multiparametric Modular Model 66S Monitor 
(Hewlett-Packard USA) was used for non-invasive 
measurements of hemodynamic parameters as well as to 
monitor parameters related to gas exchange. This monitor 
is routinely used for inpatients in ICUs. The recorded 
parameters were heart rate (HR = bpm); systolic, diastolic, 
and mean arterial pressures (SAP, DAP, MAP = mmHg); 
and peripheral oxygen saturation (SpO2 = %). All of these 
parameters were recorded by a portable computer at the 
times designated by our protocol.
The protocol was initiated and the patient was transferred 
from previous ventilation parameters in PS to the first 
method, as determined by randomization. Parameters were 
registered at Time 1: one minute after the installation of the 
designated weaning mode, and at Time 30: 30 minutes after 
the first measurement. Thirty minutes after the beginning 
of the first weaning method, the patient was put back on 
mechanical ventilation for at least 30 minutes, under the 
same ventilation parameters used prior to the beginning 
of the protocol. This period was intended to allow for 
respiratory rest and to restore the parameters to which 
the patient had been exposed before the beginning of the 
protocol. Thereafter, the second weaning method was 
tested.
As described in the literature, the criteria for interrupting 
our protocol included signs of respiratory distress, a drop in 
oxygen saturation
 
(< 88%), an increase in the respiratory rate 
(> 35 bpm) and heart rate (> 140 bpm), SAP > 180 mmHg 
or < 90 mmHg, agitation, and a change or reduction in the 
degree of alertness. 
Data Analysis
Initially, a general analysis of the entire sample condition 
(n=40) was performed, as well as an analysis of each 
condition under the two treatment methods at the various 
time points. Variables were analyzed by comparing T-tube 
(control) and EPAP treatments at the first and thirtieth 
minutes. 
Patients were also analyzed in subconditions to compare 
COPD versus non-COPD patients. Stata 8.0 was used for 
data storage and analysis. Results are represented in terms 
of means and standard deviations for continuous variables 
that are normally distributed, and as ratios for categorical 
variables. Comparisons were made using the Student t-test 
for paired samples. Significance was established at p<0.05.
RESULTS
The clinical characteristics of the 40 enrolled patients are 
shown in Table 1. All patients completed the protocol.
Mechanical ventilation parameters of patients before they 
entered the protocol were PS level =10±2 cmH2O, PEEP 
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=5±1 cmH2O, FiO2 =38±2, VT = 525±155 ml, and RR = 
20±5 rpm. 
Arterial blood gas analysis performed within one hour 
prior to commencing the protocol showed pH = 7.43±0.2, 
PaCO2 = 35±8, HCO3 = 24±2, PaO2 = 96±15, and oxygen 
saturation = 97±3%.
Hemodynamic and Respiratory Measurements 
With regard to respiratory rate, we observed an increase 
between the first and the thirtieth minutes with the EPAP 
method (p<0.01) (Table 2). No differences were observed 
when comparing COPD and non-COPD, and tracheo and 
non-tracheo categories. 
No significant differences were identified in terms of 
heart rate, mean arterial pressure and peripheral oxygen 
saturation.
 Analysis of respiratory effort and comparisons between 
the EPAP and T-tube methods showed a greater WOB total 
within the EPAP condition, when comparing across the 
entire condition as well as between all COPD and non-
COPD subconditions, in both the first and thirtieth minutes 
(Figures 1, 2 and 3).
DISCUSSION
Our results suggest that EPAP caused an increase 
in the work of breathing. No differences were observed 
for the other hemodynamic and respiratory parameters. 
These observations were made by analyzing the entire 
Table 2 - Hemodynamic and Respiratory Measurements: Comparison between EPAP and T-tube methods. 
         
 EPAP p-value * T-tube p-value *
 0 - 30 minutes  0 - 30 minutes  
HR ALL 96.2 (17.9)-99 (18.2) NS 89.9 (21.3)-98.0 (22.8) NS
HR  COPD, bpm  88.2 (18.1)-91.5 (29.5) NS 93.7 (14.7)-95.6 (18.0) NS
HR non-COPD, bpm 97.46 (19.5)-100.9 (18.1) NS 93.5 (18.8)-99.0 (17.0) NS
p-value ***  NS  NS
MAP ALL 96.4 (12.5)-97.1 (13.2) NS 94.4 (11.8)-96.3 (12.2) NS
MAP  COPD, mmHg 93.5 (14.7)-92.6 (1.4) NS 95. (12.7)-94.1 (11.1) NS
MAP non-COPD, mmHg 94.0 (20)-95.5 (21.1) NS 94.8 (10.1)-98.3 (11.8) NS
p-value ***  NS  NS
RR ALL 24.7 (6.1)-28.8 (8.1) p<0.01 26.8 (7.9)-27.6 (6.9) NS
RR   COPD, rpm 24.3(5.1)-28.7 (6.6) NS 28.3(8.7)-27.6 (6.5) NS
RR non-COPD, rpm 23.8 (6.5)-28.8 (8.9) p<0.01 25.9 (7.4)-27.6 (7.2) NS
p-value ***  NS  NS
SpO2 ALL 96.1 (3.1)-95.6 (3.9) NS 95.3 (2.5)-94.8 (3.7) NS
SpO2   COPD, % 96.5 (2.9)-96 (4.1) NS 95.7 (2.3)-94.4 (3.7) NS
SpO2  non-COPD, % 95.8 (3.2)-95.3 (3.8) NS 95.3 (2.6)-95.0 (3.7) NS
p-value ***  NS  NS
Comparison between EPAP and T-tube methods. EPAP= Positive Expiratory Airway Pressure; HR = Heart Rate; MAP = mean arterial pressure; RR = 
Respiratory Rate; SpO2 = peripheral oxygen saturation; COPD = Chronic Obstructive Pulmonary Disease; non-COPD = non Chronic Obstructive Pul-
monary Disease.  * Student t-test comparing times 1 and 30; 
** Student t-test comparing times 1 and 30; 
*** Student t-test comparing COPD and non-COPD. Values expressed as means and standard deviations
Analysis of respiratory work comparing EPAP and T-tube methods showed a greater WOB total under the EPAP method, within the entire condition as 
well as between all COPD and non-COPD subconditions, both in the first and the thirtieth minutes (Figures 1, 2 and 3)
Figure 1 - Work of Breathing in the study population: Comparison between 
EPAP and T-tube methods. EPAP= Positive Expiratory Airway Pressure. 
Values expressed in Joules/L. * Student t-test comparing EPAP ant T-tube 
methods: p<0.05
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sample condition as well as the COPD and non-COPD 
subconditions.
It  is important to note that EPAP is used by 
physiotherapists in certain situations but has not been 
evaluated to date in the context of weaning patients 
from mechanical ventilation. Some of its beneficial 
effects in preventing atelectasis and in clearing secretions 
may be useful in this context, because it is known that 
supplementary EPAP is useful in mobilizing secretions and 
treating atelectasis.5,9,13 We also know that other forms of 
PEP are helpful in preventing lung collapse and in removing 
pulmonary secretions. Recently, Positive Airway Pressure 
(PAP) devices have been used to treat patients with sleep-
related breathing disorders.10 CPAP has been shown to be 
associated with reinsufflation of collapsed lung areas and 
may exert a potential bronchial cleaning effect, associated 
with an increase in transpulmonary pressure.14,15 PEP was 
associated with increases in lung volume and removal of 
pulmonary secretions. The most likely explanation for these 
beneficial effects of expiratory pressure is the improvement 
of lung collateral ventilation and probably a reduction in 
air trapping. These effects in the context of positive airway 
pressure may be beneficial in reducing respiratory work. 
However, the implementation of CPAP requires a flow 
system that incorporates specific flow-generating valves or 
supplementary hardware in the mechanical respirator itself. 
Our EPAP study aimed to evaluate a low-cost, spontaneous 
breathing system. We wished to achieve beneficial effects 
similar to those associated with CPAP, but we failed to meet 
these goals. 
Comparison between T-tube and EPAP methods showed 
no significant differences in hemodynamic measurements 
and SpO2. Therefore, we suggest that these approaches are 
not harmful, at least in terms of oxygenation. However, there 
was a significant increase in WOB during EPAP use.
Significant increases in WOB totals were related to 
increased respiratory work under the EPAP protocol, as 
compared to the T-tube method. There are no data in the 
literature regarding such a comparison. Measurement 
of WOB is quite complex and is better reproduced by 
experimental models. Nevertheless, measurements can 
be recorded in patients with spontaneous, assisted, or 
controlled breathing.16 WOB totals reflect the effort needed 
to overcome elastic forces (compliance) of the pulmonary 
parenchyma and of the thoracic wall, as well as viscous 
forces (resistance) attributed to the airways, lungs and 
thoracic wall tissues.16 WOB measurements reflect the 
strength of an individual’s respiratory muscles in regard 
to the reserves needed to return to spontaneous respiration 
(patient work).16-19 WOB is commonly increased in critically 
ill patients, but many patients have a decreased capacity for 
working performance. The level of expiratory pressure used 
during the EPAP method, even though it was low, imposed 
an increase in the expiratory resistance. Consequently, there 
was also a substantial inspiratory load, probably due to an 
increase in negative intrapleural pressure generated before 
the commencement of inspiratory flow. This may explain 
the increase in WOB as well as in respiratory rate in the 
EPAP condition. Nevertheless, a very important point in this 
study is the fact that a greater WOB was observed in all the 
subconditions studied.
Regarding limitations of this study, we wish to highlight 
the small number of subjects and we note the heterogeneity 
of diseases causing respiratory failure that can cause different 
responses. It is also important to point out that no invasive 
monitoring strategy was used because all patients had their 
respiratory failure adequately controlled and were not only 
being weaned from mechanical ventilation, but also from 
more aggressive monitoring systems. 
Nevertheless, the greater WOB data was observed in 
all subconditions studied, and we think this result is of 
interest.
Figure 2 and 3 - Work of Breathing: Comparison between EPAP and T-tube methods in subconditions COPD and non-COPD. EPAP= Positive Expira-
tory Airway Pressure; COPD = Chronic Obstructive Pulmonary Disease; non-COPD = non Chronic Obstructive Pulmonary Disease. Values expressed in 
Joules/L. * Student t-test comparing EPAP ant T-tube: p<0.05
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In conclusion, our study demonstrated that in weaning 
patients from mechanical ventilation, the use of a fixed level 
of positive expiratory airway pressure caused an increase in 
WOB without other significant cardiorespiratory changes. 
Therefore, we must be cautious when using EPAP as a 
physiotherapeutic tool during weaning from mechanical 
ventilation.
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